HONG KONG, Dec. 24, 2024 /PRNewswire/ -- With air pollution posing a growing global health threat, QNET's HomePure Zayn remains a household staple, delivering pure, revitalised indoor air. As we enter 2025, HomePure Zayn is more essential than ever, trusted by families worldwide to protect their homes from pollutants and ensure a healthier, cleaner living environment.
Advanced Technology, Proven Results
The HomePure Zayn air purifier features a powerful six-stage filtration system that eliminates 99.94% of airborne viruses, including SARS-CoV-2 variants, and 99.8% of allergens, particulates, and harmful volatile organic compounds (VOCs). Combining HPP+ Electrostatic Film, UV Light, and Ultra-Plasma Ion Filters, it delivers comprehensive air purification for safe and healthy indoor environments.
Trevor Kuna, Chief Marketing Officer of QNET, explains, "What sets HomePure Zayn apart is QNET's exclusive Amezcua Card. This proprietary technology not only purifies but also energises the air, enhancing overall well-being. By harmonising air molecules, the Amezcua Card creates a revitalised indoor atmosphere, with users reporting benefits like better sleep, improved mental clarity, and refreshed energy."
Why Clean, Energized Air Matters
With air pollution linked to seven million deaths globally each year, as reported by the World Health Organization, indoor air—often five times more polluted than outdoor air—poses a significant health risk. Studies show that advanced air filtration systems can dramatically improve respiratory health, especially for children, the elderly, and those with chronic conditions. With close to 1500 users globally, HomePure Zayn provides a critical solution, delivering clean, energized air to protect and enhance family well-being.
Certified for Excellence
HomePure Zayn is certified by the European Centre for Allergy Research Foundation (ECARF), ensuring it meets the highest air purification standards. Paired with the Amezcua Card's revitalising technology, it offers an unmatched solution for cleaner, healthier living spaces.
Pranee Sranthongdee, who has been using the HomePure Zayn since 2020, shared her experience, saying, "My daughter's allergy symptoms have noticeably improved, and I've observed that my children breathe better. When I checked the filter, it was filled with dust, which shows that the HomePure Zayn has been effectively cleaning the room and providing clean air."
Start Fresh in 2025
Let's welcome 2025 with clean, energised air as our priority. Join thousands of households worldwide that trust HomePure Zayn for improved air quality and wellness. For more information, visit www.qnet.net.
ABOUT QNET
QNET, a global lifestyle and wellness company, uses a direct selling business model to promote unique products that enable people to take charge of their health, well-being, and lifestyle.
Since 1998, QNET's innovative products and e-commerce-driven business model have helped build a global community of satisfied customers and microentrepreneurs, who are driven by the mission of RYTHM – Raise Yourself To Help Mankind. Popular product brands offered by QNET include the Bernhard H. Mayer range of luxury watches and jewellery, HomePure range of home care products, the Amezcua wellness range, Physio Radiance personal care range, and QVI branded holiday packages.
QNET proudly exemplifies high industry standards and is a member of numerous Direct Selling Associations worldwide. Its active engagement in several global sports sponsorships including in its role as the official direct selling partner of the Manchester City Football Club (MCFC) and the Confederation of African Football (CAF), highlights the company's commitment to excellence.
Discover a world of new possibilities with QNET by visiting www.qnet.net.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Step Into 2025 with Fresh Air: QNET's HomePure Zayn Sets the Standard for Clean, Healthy Living
HEIDELBERG, Germany, Dec. 25, 2024 /PRNewswire/ -- European Wellness Biomedical Group (EWBG) has launched a new research initiative focused on Klotho, a protein with transformative potential in longevity medicine. Led by Professor Dr. Mike Chan, this project will explore Klotho's role in combating age-related diseases and its ability to regenerate critical organs, including the brain, kidneys, and heart.
Klotho, identified in 1997, is emerging as a key protein in longevity and regenerative medicine. It plays a pivotal role in regulating oxidative stress, mineral metabolism, and inflammation. The research will investigate how boosting Klotho levels could help address chronic conditions like neurodegenerative diseases, kidney failure, and heart disease, ultimately improving healthspan and extending lifespan.
"Klotho represents the next frontier in longevity medicine," said Professor Mike Chan, Chief Scientist at EWBG. "Our research aims to understand how Klotho affects aging and how we can use it to treat chronic diseases that have long been associated with aging."
Research Focus Areas
The new initiative will focus on three primary research areas:
This research builds on existing collaborations at EWBG, where leading scientists focus on advancing Klotho-based therapies for regenerative health.
Klotho: A Potential Breakthrough in Longevity Medicine
Klotho is gaining attention for its ability to regenerate tissues and reverse damage caused by age-related diseases. Unlike NAD+, which primarily enhances cellular metabolism and energy production, Klotho offers a broader range of therapeutic applications, including tissue regeneration, cognitive function improvement, and cardiovascular health.
As we age, Klotho levels naturally decline, leading to conditions such as cognitive decline, heart disease, and kidney failure. Research suggests that restoring Klotho levels can reverse the effects of oxidative stress, inflammation, and cellular senescence, offering new treatment possibilities for a range of age-related diseases.
Professor Mike Chan: Leading the Charge in Klotho Research
Professor Mike Chan, a leading expert in stem cell therapy and longevity medicine, is spearheading this groundbreaking initiative at EWBG. His extensive experience in bio-regenerative medicine positions him as a key figure in exploring Klotho's potential to revolutionize the treatment of age-related diseases. Through FCTI, a subsidiary of EWBG, Professor Chan and his team are developing therapies that combine stem cell technology and Klotho proteins to stimulate tissue regeneration in the brain, kidneys, and heart.
"By harnessing Klotho's regenerative properties, we hope to address chronic conditions that were previously untreatable," said Professor Chan. "Our ultimate goal is to improve quality of life and provide lasting solutions for those affected by aging-related diseases."
The Future of Klotho in Longevity Medicine
The future of Klotho-based therapies looks promising, with Professor Mike Chan and EWBG at the forefront of this innovative field. As more research is conducted, Klotho is expected to play a pivotal role in advancing longevity medicine, offering a new approach to treating aging and chronic diseases. The potential applications of Klotho are vast, from neurodegenerative disease treatment to kidney regeneration and cardiovascular health.
With strong research partnerships, significant funding, and ongoing clinical trials, Klotho is poised to become a cornerstone of longevity medicine, transforming how we approach aging and disease. Professor Mike Chan's leadership ensures that this promising protein will soon offer new hope to those seeking longer, healthier lives.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
European Wellness Biomedical Group Announces New Klotho Research Initiative Led by Prof. Mike Chan